GLP-1 and Muscle Loss: How to Protect Lean Mass

Yes, GLP-1 medicines such as semaglutide and tirzepatide cause some muscle loss: across the major trials, lean mass has made up roughly 25 to 40 percent of total weight lost, depending on the study and the person. Most of that loss is manageable with enough protein, regular resistance training, eating enough overall and a slow dose titration under medical supervision.

The figure is not fixed. The highest lean mass shares come from trial groups who were mostly sedentary and not eating a high protein diet. The habits below can protect most of your lean mass while you keep losing fat.

Why GLP-1 medicines cause muscle loss in the first place

This is not a quirky side effect of the drug. It is mostly basic physiology. Whenever you lose weight quickly, your body draws on both fat and lean tissue. The faster and larger the weight loss, the more lean mass tends to come along for the ride.

GLP-1 receptor agonists (semaglutide, sold as Wegovy for weight and Ozempic for type 2 diabetes) and the dual GIP/GLP-1 receptor agonist tirzepatide (Zepbound for weight, Mounjaro for diabetes) produce some of the fastest, largest weight loss we have seen from a pill or injection. That makes muscle loss a real consideration rather than an afterthought.

Two things drive it:

• Rapid, substantial weight loss. Any significant calorie deficit pulls from muscle as well as fat. These medicines create a strong deficit by quieting appetite, so the deficit can be larger than what most people achieve through diet alone.
• Reduced food intake, especially protein. The appetite suppression is the point of the medicine, but it often means people simply eat less of everything, protein included. Without enough dietary protein and without a reason for the body to hold onto muscle, lean tissue gets broken down.

It is worth being honest about the numbers because they vary. In the semaglutide STEP-1 analysis, lean mass made up roughly 40 to 45 percent of total weight lost. In the tirzepatide SURMOUNT-1 analysis, the figure was closer to 25 to 26 percent. Different trials, different body composition methods, and different populations produce different results, which is exactly why you should treat any single headline percentage with caution.

The trials that show the highest lean mass loss were generally done in people who were sedentary, not eating high protein, and not training. That is the key insight: the percentage is not fixed. It responds to what you do.

What the two landmark trials measured

The STEP 1 trial, reported by Wilding and colleagues in the New England Journal of Medicine (2021), tested semaglutide 2.4 mg once weekly for 68 weeks and measured body composition by dual energy X-ray absorptiometry (DEXA) in a subgroup. The SURMOUNT-1 trial, reported by Jastreboff and colleagues in the same journal (2022), tested tirzepatide at 5, 10 and 15 mg weekly for 72 weeks, also with a DEXA substudy. Neither trial required participants to follow a structured strength program, which is part of why their lean mass figures look high.

Why lean mass matters more than people realize

Muscle is not just for appearance or athletics. It does quiet, important work:

• Metabolism. Muscle is metabolically active tissue. Lose too much of it and your resting energy expenditure drops, which can make weight maintenance harder later.
• Strength and physical function. Lean mass supports everyday capability, from carrying groceries to climbing stairs. This matters at every age and becomes critical as people get older.
• Long-term weight maintenance. Preserving muscle helps protect the metabolic machinery you will rely on if you ever come off the medicine or reduce the dose. Losing fat while keeping muscle is a far more durable outcome than losing weight indiscriminately.
• Metabolic health. Skeletal muscle is a major site for glucose disposal. Keeping it supports blood sugar regulation and insulin sensitivity, which is often part of the reason people are on these medicines to begin with. Our guide to the signs of insulin resistance covers that link in more detail.

The goal is not to lose less weight. It is to make sure the weight you lose is mostly fat.

Who is most at risk of losing muscle on a GLP-1?

Adults over about 60 face the highest stakes, because muscle mass and strength already decline with age, a process called sarcopenia. Losing a large share of lean mass during weight loss can speed that decline and raise the risk of falls and frailty. People with existing sarcopenic obesity, where low muscle mass and excess fat occur together, are in a similar position.

Risk also rises with habits rather than age alone. People who are sedentary, who eat well below their protein needs, who lose weight very quickly, or who have had bariatric surgery or a long illness tend to lose more lean tissue. Postmenopausal women deserve particular attention, since lower estrogen already affects muscle and bone; our guide to menopause weight gain covers that overlap.

The evidence-based countermeasures

Here is the encouraging part. The same strategies that preserve muscle during any weight loss work here, and the data on combining them is genuinely good. In one six-month study of about 200 adults who were taught resistance training and adequate protein intake when they started a GLP-1 medicine, participants lost roughly 13 percent of body weight but only around 3 percent of muscle mass. That is a dramatically better ratio than what the early sedentary trials showed.

1. Eat enough protein

Protein is the single most important nutritional lever for keeping muscle in a calorie deficit. The general guidance discussed in the literature for preserving lean mass during weight loss sits around 1.2 to 1.6 grams of protein per kilogram of body weight per day. People who are training hard may benefit from the higher end or slightly above, in the region of 1.6 to 2.2 g/kg. These are general ranges, not prescriptions, and the right target depends on your size, age, kidney health, and activity level, so confirm yours with your prescriber or a dietitian.

The practical challenge on a GLP-1 medicine is that you are not very hungry. That makes it easy to fall short. A few habits help: eat protein first at each meal, prioritize dense sources like eggs, dairy, fish, poultry, lean meat, tofu, and legumes, and consider a protein shake on days when solid food feels like too much.

The arithmetic is simple once you know your weight in kilograms. The table below applies the 1.2 to 1.6 g/kg range to three example body weights.

For people with a lot of weight to lose, many dietitians calculate protein from a target or adjusted body weight rather than current weight, which gives a lower and more realistic number. Splitting the total across three or four meals is usually easier than eating it in one sitting when appetite is low.

2. Do resistance training

Protein gives your body the raw material. Resistance training gives it a reason to use that material for muscle rather than burn it for fuel. The research is consistent that protein and lifting together preserve more muscle than either one alone. Protein without the mechanical load of resistance work does not fully protect lean mass.

You do not need to become a bodybuilder. Two to three sessions a week covering the major movement patterns, with enough effort to be challenging, is a reasonable starting point. Bodyweight work, resistance bands, machines, or free weights all count. Progressing the difficulty over time is what matters most.

A simple full body session covers five patterns:

1. A squat or leg press for the thighs and hips.
2. A hip hinge such as a deadlift, hip thrust or bridge for the back of the body.
3. A push such as a push up, chest press or overhead press.
4. A pull such as a row, lat pulldown or band pull.
5. A carry or plank for the trunk.

Walking and other aerobic exercise help heart health and appetite regulation, but they do not replace lifting for muscle retention. If you have joint pain, a physical therapist can adapt these movements; our page on osteoarthritis explains why lower body weight and stronger thigh muscles both matter for painful knees.

3. Do not under-eat

Because these medicines suppress appetite so effectively, some people drift into eating far too little overall. An extreme deficit accelerates muscle loss and can leave you fatigued and nutrient-deficient. Losing weight at a steady, moderate pace, while still eating real meals, protects lean mass better than crash-style restriction. Eating enough is a strategy, not a contradiction.

Nausea, early fullness and constipation make this harder in the first weeks after each dose step. Smaller, more frequent meals and protein you can drink tend to help; our overview of semaglutide side effects covers the digestive effects in more depth.

4. Titrate the dose slowly

Faster weight loss tends to mean more lean mass loss. A gradual dose increase, guided by your prescriber, generally produces a steadier rate of loss that is easier on your muscle and on your digestion. There is no prize for getting to the maximum dose quickly. This is a decision to make with your clinician, not on your own.

5. Emerging adjuncts

This area is moving quickly, and it is worth understanding without overstating it. Researchers are testing medicines designed specifically to preserve muscle during GLP-1 weight loss. Bimagrumab, an antibody that blocks activin type II receptors involved in myostatin signaling, has shown in early-phase trials that combining it with semaglutide can shift a much larger share of weight loss toward fat while protecting or even increasing lean mass. Other myostatin-pathway agents are in development.

These are promising but still investigational. They are not a substitute for protein and training, and they are not something to pursue on your own. Mention them to your prescriber if muscle loss is a particular concern, and watch the space as the data matures.

Some clinics also market growth hormone secretagogue peptides, such as sermorelin or CJC-1295 with ipamorelin, as muscle protection during GLP-1 treatment. Evidence for that specific use is thin, and these compounds are not FDA approved for it. Our peptide therapy treatment guide sets out what is and is not known.

How do you know if you are losing muscle on a GLP-1?

A body composition test is the only reliable way to know, because a bathroom scale reports total weight and cannot separate fat from muscle. DEXA, the same method used in the STEP 1 and SURMOUNT-1 substudies, measures fat mass, lean mass and bone. Clinical bioimpedance analysis (BIA) is cheaper and more widely available, but readings shift with hydration, so test under the same conditions each time.

Simple function checks add useful context between scans. Watch for these signs:

• Your lifts or reps are falling week after week even though you are training consistently.
• Grip strength, stair climbing or standing up from a chair feels harder than it did.
• Your waist measurement is barely changing while your weight drops quickly.
• You feel unusually weak or tired, which can also point to eating too little.

A baseline scan before you start, then a repeat every few months, gives you and your prescriber a clear picture of what kind of weight you are losing.

What happens to muscle when you stop semaglutide or tirzepatide?

Weight tends to return after stopping, and without strength training the regained weight does little to rebuild the muscle that was lost. In the STEP 1 extension, reported by Wilding and colleagues in Diabetes, Obesity and Metabolism (2022), participants regained about two thirds of the weight they had lost within a year of stopping semaglutide. Lean mass lost during treatment does not come back on its own the way fat does.

That is why the muscle you protect during treatment matters so much. Keeping your strength work and protein intake in place before, during and after any dose reduction is the most practical way to hold onto lean mass. Our article on GLP-1 weight loss plateaus covers what changes when progress slows.

Does this apply to both semaglutide and tirzepatide?

Yes. Lean mass loss is a feature of rapid weight loss generally, so it applies to both semaglutide and tirzepatide, and to the dual and triple agonists now coming through trials. Some analyses suggest tirzepatide may have a somewhat more favorable lean-to-fat loss ratio, but the differences are modest and the data is still developing. The protective strategies are the same regardless of which medicine you are on. If you are weighing the two, our comparison of semaglutide versus tirzepatide and our guide to tirzepatide for weight loss go deeper.

Does it apply to compounded versions and newer agonists?

Yes. Compounded semaglutide and compounded tirzepatide contain the same active ingredients, so the same muscle protection habits apply. The FDA has stated its concerns about unapproved GLP-1 drugs used for weight loss, because compounded products are not reviewed for safety, quality or effectiveness the way approved medicines are. Our treatment guides to compounded semaglutide and compounded tirzepatide explain the differences. Retatrutide, an investigational triple agonist, is covered in our retatrutide guide.

A word on medical supervision

Semaglutide and tirzepatide are prescription medicines. Dosing, titration, protein targets, and any adjunct therapy should be decided with a qualified clinician who knows your full history, including kidney function and any other conditions. Body composition is also worth tracking with something better than a bathroom scale, since the scale cannot tell muscle from fat. A DEXA scan or a clinical bioimpedance assessment gives you a real picture of what you are actually losing.

The clinicians involved usually include an obesity medicine or primary care physician, a nurse practitioner or physician assistant who manages titration, a registered dietitian for protein targets, and a physical therapist or qualified trainer for strength work. Many metabolic, functional medicine and weight management clinics offer this kind of team approach alongside GLP-1 prescribing.

Where to find clinicians who monitor body composition

Clinics that prescribe GLP-1 medicines often sit within peptide and metabolic health practices. You can browse peptide therapy clinics across the US and ask each one whether it offers baseline and follow-up body composition testing, dietitian support and a strength plan. Listing order on Regenerated.com is not paid ranking, Featured slots are clearly labeled and capped, and Verified means a clinic has completed our credential checks rather than paid for placement. The directory is free for patients, and inclusion in it is not an endorsement; our guide to Featured, Verified and organic listings explains each label.

Frequently asked questions

How much muscle will I lose on semaglutide or tirzepatide?

It depends heavily on what you do. In sedentary trial populations, lean mass has accounted for roughly 25 to 40 percent of total weight lost, with the STEP 1 semaglutide substudy near the top of that range and the SURMOUNT-1 tirzepatide substudy near the bottom. With adequate protein and regular resistance training, studies suggest muscle loss can be cut to a small fraction of total weight lost, with most of the weight coming from fat.

How much protein should I eat on a GLP-1 medicine?

General guidance for preserving muscle during weight loss is around 1.2 to 1.6 grams per kilogram of body weight per day, with higher amounts sometimes used by people training intensely. For a 90 kg adult that works out to roughly 108 to 144 grams a day, spread across meals. The right target for you depends on your size, age, activity, and kidney health, so confirm it with your prescriber or a dietitian.

Can I rebuild muscle while staying on the medicine?

Yes. With sufficient protein and consistent resistance training, many people maintain or even build strength while continuing to lose fat. The medicine does not prevent muscle growth. The main obstacle is usually eating enough protein when your appetite is suppressed, so protein first meals, shakes on low appetite days and two to three progressive strength sessions a week are the practical levers.

Is muscle loss a reason to avoid these medicines?

Not by itself. For most people the metabolic benefits of significant fat loss are substantial, and muscle loss is largely preventable with the right habits. The sensible approach is to use the medicine under medical supervision while actively protecting your lean mass, rather than avoiding effective treatment. Older adults and people with low muscle mass should raise it with their prescriber before starting.

What is the best way to measure muscle loss on a GLP-1?

A DEXA scan is the most accurate widely available test, and it is the method the STEP 1 and SURMOUNT-1 trials used to measure lean mass. Clinical bioimpedance analysis is a cheaper alternative, but hydration changes its readings, so test at the same time of day under the same conditions. A baseline before starting and a repeat every few months shows whether you are losing fat or muscle.

Do I lose muscle in my face on Ozempic?

The hollow look some people call Ozempic face comes mainly from losing facial fat during rapid weight loss, not from losing facial muscle. It can happen with semaglutide, tirzepatide or any large weight loss. A slower, steadier rate of loss, enough protein and good hydration support overall body composition, but facial fat changes are largely tied to how much and how quickly weight comes off.

Related reading

• Semaglutide vs Tirzepatide: How They Compare
• Tirzepatide for Weight Loss
• Peptide Therapy: What It Is and How It Works
• NAD+ IV Therapy and Anti-Aging

This article is for general educational purposes and is not medical advice. Semaglutide and tirzepatide are prescription medicines that should be used only under the supervision of a qualified healthcare professional. Always consult your own clinician before starting, stopping, or changing any treatment, supplement, protein target, or exercise program, particularly if you have an existing medical condition.